U
Ultimovacs ASA
F:7UM
Ultimovacs ASA
F:7UM
Price:
1.066
EUR
-0.93%
Market Cap:
€36.7m
Balance Sheet
Balance Sheet Decomposition
Ultimovacs ASA
Ultimovacs ASA
Balance Sheet Decomposition is not available for
Ultimovacs ASA
Ultimovacs ASA
Balance Sheet
Ultimovacs ASA
Ultimovacs ASA
Currency: NOK
| Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
73
|
170
|
116
|
400
|
441
|
574
|
425
|
267
|
|
| Cash |
72
|
169
|
115
|
398
|
439
|
572
|
423
|
265
|
|
| Cash Equivalents |
1
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
|
| Short-Term Investments |
5
|
4
|
5
|
6
|
7
|
5
|
5
|
3
|
|
| Total Receivables |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
|
| Other Current Assets |
0
|
0
|
0
|
2
|
1
|
2
|
4
|
1
|
|
| Total Current Assets |
78
|
175
|
122
|
408
|
449
|
582
|
436
|
272
|
|
| PP&E Net |
1
|
1
|
1
|
4
|
4
|
2
|
6
|
4
|
|
| PP&E Gross |
1
|
1
|
1
|
4
|
4
|
2
|
6
|
4
|
|
| Accumulated Depreciation |
0
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
|
| Intangible Assets |
4
|
3
|
56
|
56
|
65
|
60
|
58
|
62
|
|
| Goodwill |
0
|
0
|
11
|
11
|
12
|
11
|
11
|
12
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
0
|
0
|
11
|
11
|
12
|
11
|
11
|
12
|
|
| Total Assets |
83
N/A
|
179
+116%
|
190
+6%
|
478
+152%
|
530
+11%
|
656
+24%
|
510
-22%
|
349
-32%
|
|
| Liabilities | |||||||||
| Accounts Payable |
2
|
3
|
3
|
12
|
9
|
23
|
8
|
11
|
|
| Accrued Liabilities |
2
|
3
|
4
|
5
|
10
|
10
|
18
|
12
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
1
|
2
|
2
|
2
|
2
|
|
| Other Current Liabilities |
1
|
6
|
12
|
2
|
7
|
16
|
19
|
31
|
|
| Total Current Liabilities |
5
|
12
|
19
|
20
|
27
|
51
|
46
|
56
|
|
| Long-Term Debt |
0
|
0
|
0
|
2
|
2
|
0
|
4
|
2
|
|
| Deferred Income Tax |
0
|
0
|
11
|
11
|
12
|
11
|
11
|
12
|
|
| Other Liabilities |
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
7
N/A
|
12
+81%
|
30
+143%
|
33
+12%
|
41
+24%
|
62
+51%
|
60
-3%
|
70
+15%
|
|
| Equity | |||||||||
| Common Stock |
1
|
1
|
1
|
3
|
3
|
3
|
3
|
3
|
|
| Retained Earnings |
70
|
103
|
158
|
219
|
340
|
504
|
672
|
861
|
|
| Additional Paid In Capital |
145
|
268
|
314
|
657
|
809
|
1 071
|
1 076
|
1 077
|
|
| Other Equity |
0
|
0
|
3
|
4
|
16
|
23
|
42
|
61
|
|
| Total Equity |
76
N/A
|
166
+120%
|
160
-4%
|
445
+178%
|
488
+10%
|
593
+21%
|
449
-24%
|
279
-38%
|
|
| Total Liabilities & Equity |
83
N/A
|
179
+116%
|
190
+6%
|
478
+152%
|
530
+11%
|
656
+24%
|
510
-22%
|
349
-32%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
28
|
28
|
28
|
28
|
32
|
34
|
34
|
34
|
|
Switch to:
Switch to:
See Also
Discover More
